• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童新冠病毒病的临床概况:现有文献综述

Clinical Profile of Covid-19 in Children, Review of Existing Literatures.

作者信息

Tiruneh Firew Tiyare

机构信息

Department of Midwifery, College of Health Science, Mizan Tepi University, Mizan Teferi, Ethiopia.

出版信息

Pediatric Health Med Ther. 2020 Sep 21;11:385-392. doi: 10.2147/PHMT.S266063. eCollection 2020.

DOI:10.2147/PHMT.S266063
PMID:33061744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7518768/
Abstract

WHO has confirmed that COVID-19 disease is a pandemic on March 11, 2020. The disease is caused by a new virus called SARS-CoV-2. Since, the pandemic was announced around 18,854,287 cases and 708,639 deaths were reported as of August 7, 2020. This review aimed to explore the etiology, pathogenesis, manifestation and complication. The phylogenetic study showed that SARS-CoV-2 is a single-stranded RNA virus. The virus is very contagious and has rapidly spread globally. Its unique structure called S glycoproteins help the virus enters in and cause infection in the body. Children's body reacts against SARS-CoV-2 infections through the involvement of innate and adaptive immune system. The clinical manifestation in children is not specific and not determined. However, fever and cough have mostly been profiled. Though the severe condition is rarely reported in children compared with adults, life-threatening complications, and death associated with COVID-19 disease have been documented. Underlying chronic pulmonary disease, cardiovascular disease, immunosuppression, and obesity significantly contribute to the complications.

摘要

世界卫生组织于2020年3月11日确认新型冠状病毒肺炎为大流行病。该疾病由一种名为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新型病毒引起。自宣布该大流行病以来,截至2020年8月7日,报告的病例约为18854287例,死亡708639例。本综述旨在探讨其病因、发病机制、表现及并发症。系统发育研究表明,SARS-CoV-2是一种单链RNA病毒。该病毒具有很强的传染性,已在全球迅速传播。其名为S糖蛋白的独特结构有助于病毒进入人体并引发感染。儿童机体通过固有免疫系统和适应性免疫系统对SARS-CoV-2感染作出反应。儿童的临床表现不具特异性且尚无定论。不过,发热和咳嗽最为常见。尽管与成人相比,儿童中严重病例较少见,但与新型冠状病毒肺炎相关的危及生命的并发症和死亡已有记录。潜在的慢性肺部疾病、心血管疾病、免疫抑制和肥胖显著促成了并发症的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fc/7518768/04b9ae751d86/PHMT-11-385-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fc/7518768/6fbeb380ea3f/PHMT-11-385-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fc/7518768/04b9ae751d86/PHMT-11-385-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fc/7518768/6fbeb380ea3f/PHMT-11-385-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72fc/7518768/04b9ae751d86/PHMT-11-385-g0002.jpg

相似文献

1
Clinical Profile of Covid-19 in Children, Review of Existing Literatures.儿童新冠病毒病的临床概况:现有文献综述
Pediatric Health Med Ther. 2020 Sep 21;11:385-392. doi: 10.2147/PHMT.S266063. eCollection 2020.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
4
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
5
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective.从分子机制和免疫反应角度治疗新冠肺炎的当前方法。
Saudi Pharm J. 2020 Nov;28(11):1333-1352. doi: 10.1016/j.jsps.2020.08.024. Epub 2020 Sep 1.
6
COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.儿童、妊娠和新生儿中的 COVID-19:流行病学和临床特征综述。
Pediatr Infect Dis J. 2020 Jun;39(6):469-477. doi: 10.1097/INF.0000000000002700.
7
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
8
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
9
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
10
A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.2022 年 4 月,伊朗西南部一小部分儿童出现了 COVID-19 大流行期间呼吸道合胞病毒(RSV)的延迟反弹:一次不可预测的暴发。
J Med Virol. 2022 Dec;94(12):5802-5807. doi: 10.1002/jmv.28065. Epub 2022 Aug 23.

引用本文的文献

1
Comparison between SARS-CoV-2 positive and negative pneumonia in children: A retrospective analysis at the beginning of the pandemic.儿童新冠病毒阳性与阴性肺炎的比较:大流行初期的回顾性分析
World J Exp Med. 2022 Mar 20;12(2):26-35. doi: 10.5493/wjem.v12.i2.26.
2
A case of coinfection of a pediatric patient with acute SARS-COV-2 with MIS-C and severe DENV-2 in Mexico: a case report.墨西哥一例儿童急性 SARS-COV-2 合并 MIS-C 和重症登革热 2 型感染的病例报告。
BMC Infect Dis. 2021 Oct 18;21(1):1072. doi: 10.1186/s12879-021-06765-6.
3
Evaluation of COVID-19 Disease and the Effect of Trends in Intervention Measures: The Pediatric Perspective from a Tertiary Care Hospital in Turkey.

本文引用的文献

1
COVID-19 in 7780 pediatric patients: A systematic review.7780例儿科患者的新冠病毒病:一项系统评价
EClinicalMedicine. 2020 Jun 26;24:100433. doi: 10.1016/j.eclinm.2020.100433. eCollection 2020 Jul.
2
Does Early Childhood Vaccination Protect Against COVID-19?幼儿接种疫苗能预防新冠病毒吗?
Front Mol Biosci. 2020 Jun 5;7:120. doi: 10.3389/fmolb.2020.00120. eCollection 2020.
3
Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD.儿童气道中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)受体血管紧张素转换酶2(ACE2)和跨膜丝氨酸蛋白酶2(TMPRSS2)的表达低于成人,并随吸烟和慢性阻塞性肺疾病(COPD)而增加。
评估 COVID-19 疾病及干预措施趋势的影响:土耳其一家三级保健医院的儿科视角。
Balkan Med J. 2021 Jul;38(4):222-228. doi: 10.5152/balkanmedj.2021.21045.
4
Emergent Pneumonia in Children.儿童急性肺炎
Front Pediatr. 2021 Jun 17;9:676296. doi: 10.3389/fped.2021.676296. eCollection 2021.
5
Seroprevalence of SARS-CoV-2 infections among children visiting a hospital.到医院就诊儿童中新冠病毒感染的血清流行率。
Pediatr Investig. 2020 Dec 28;4(4):236-241. doi: 10.1002/ped4.12231. eCollection 2020 Dec.
Mol Ther Methods Clin Dev. 2020 May 22;18:1-6. doi: 10.1016/j.omtm.2020.05.013. eCollection 2020 Sep 11.
4
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review.儿童轻度和重度 2019 年冠状病毒病(COVID-19)的实验室异常:汇总分析和综述。
Clin Biochem. 2020 Jul;81:1-8. doi: 10.1016/j.clinbiochem.2020.05.012. Epub 2020 May 27.
5
Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review.新生儿和儿童新冠病毒感染的临床特征:一项系统综述
Arch Acad Emerg Med. 2020 Apr 18;8(1):e50. eCollection 2020.
6
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality.COVID-19 患者的性别差异:关注严重程度和死亡率。
Front Public Health. 2020 Apr 29;8:152. doi: 10.3389/fpubh.2020.00152. eCollection 2020.
7
A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in 3 Febrile Infants in New York.纽约 3 例发热婴儿感染 2019 年新型冠状病毒(SARS-CoV-2)的病例系列报告。
Pediatrics. 2020 Jul;146(1). doi: 10.1542/peds.2020-1056. Epub 2020 May 13.
8
Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020.意大利多中心研究:2020 年 4 月 10 日之前 SARS-CoV-2 感染儿童和青少年的初步数据。
Euro Surveill. 2020 May;25(18). doi: 10.2807/1560-7917.ES.2020.25.18.2000600.
9
SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review.SARS-CoV-2(COVID-19):我们对儿童了解多少?系统评价。
Clin Infect Dis. 2020 Dec 3;71(9):2469-2479. doi: 10.1093/cid/ciaa556.
10
Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.美国和加拿大儿科重症监护病房收治的儿童 2019 年冠状病毒病(COVID-19)感染的特征和结局。
JAMA Pediatr. 2020 Sep 1;174(9):868-873. doi: 10.1001/jamapediatrics.2020.1948.